2002
DOI: 10.1074/jbc.m204111200
|View full text |Cite
|
Sign up to set email alerts
|

The Processing of Holliday Junctions by BLM and WRN Helicases Is Regulated by p53

Abstract: BLM, WRN, and p53 are involved in the homologous DNA recombination pathway. The DNA structure-specific helicases, BLM and WRN, unwind Holliday junctions (HJ), an activity that could suppress inappropriate homologous recombination during DNA replication. Here, we show that purified, recombinant p53 binds to BLM and WRN helicases and attenuates their ability to unwind synthetic HJ in vitro. The p53 248W mutant reduces abilities of both to bind HJ and inhibit helicase activities, whereas the p53 273H mutant loses… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
88
0
1

Year Published

2003
2003
2016
2016

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 114 publications
(94 citation statements)
references
References 58 publications
(73 reference statements)
5
88
0
1
Order By: Relevance
“…Statistical analysis showed a significant difference of this BLM binding increase between hMSH2/6 and BSA control group from 20 to 80 nM concentrations (Po0.01). Our previous report showed that 273p53, a recombinant p53 mutant protein that corresponds to a hotspot mutant found in human cancer, did not inhibit the disruption of X-junctions by BLM (Yang et al, 2002). Consistent with these data, 273p53 did not affect BLM binding to X-junctions by ELISA.…”
Section: Resultssupporting
confidence: 72%
See 2 more Smart Citations
“…Statistical analysis showed a significant difference of this BLM binding increase between hMSH2/6 and BSA control group from 20 to 80 nM concentrations (Po0.01). Our previous report showed that 273p53, a recombinant p53 mutant protein that corresponds to a hotspot mutant found in human cancer, did not inhibit the disruption of X-junctions by BLM (Yang et al, 2002). Consistent with these data, 273p53 did not affect BLM binding to X-junctions by ELISA.…”
Section: Resultssupporting
confidence: 72%
“…We investigated whether the hMSH2/6 complex modulates BLM activity on HJ by using a radiolabeled HJ mimic, a synthetic X-junction (X-12), as a substrate (McGlynn and Lloyd, 1999). As shown previously (Karow et al, 2000;Yang et al, 2002), purified recombinant BLM disrupted the X-junction (Figure 5a). hMSH2/6 stimulated BLM-mediated disruption in a dose-dependent manner.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To investigate the molecular mechanism underlying p53(WT)-mediated recombination stimulation, we silenced factors implicated in the bypass of blocked replication forks. p53 inhibits the helicase and the branch-migrating activities of Bloom syndrome protein (BLM) and Werner syndrome protein (WRN) helicases, which are involved in the regulation of HR and in the bypass of replication barriers (32,33), whereas RAD51 and breast cancer 2 (BRCA2) are involved in HR-dependent postreplication repair (34,35). Proliferating cell nuclear antigen (PCNA)-associated recombination inhibitor (PARI) associates with DNA damage sites via SUMOylated PCNA and blocks recombination by inhibition of RAD51-DNA filament formation (36).…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, hp150 is not the first common interaction partner of WRN and BLM. BLM and WRN both interact with replication protein A (RPA) (Garcia et al, 2004;Doherty et al, 2005), p53 (Spillare et al, 1999;Wang et al, 2001;Yang et al, 2002), flap endonuclease-1 (FEN-1) (Sharma et al, 2004a, b) and TRF2 Bradshaw et al, 2005). Moreover, BLM and WRN also interact with each other .…”
Section: Discussionmentioning
confidence: 99%